Financial Daily from THE HINDU group of publications
Friday, Mar 17, 2006


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Corporate - Announcements
Industry & Economy - Pharmaceuticals


Aurobindo drug gets US FDA nod

Our Bureau

Hyderabad , March 16

Aurobindo Pharma Ltd has announced that it has received the first approval for its New Drug Application (NDA) from the US Food and Drug Administration (US FDA) for Lamivudine 150 mg/ Zidovudine 300 mg fixed-dose tablets co-packed with Efavirenz 600 mg tablets.

In a press release here on Thursday, the company said this is another tentative approval through US FDA's expedited review process under President Bush's Emergency Plan for AIDS Relief (PEPFAR) initiative. Apart from several ANDA (abbreviated new drug application) approvals, the company could take advantage of the R&D skills by way of getting its first NDA.

This NDA provides Lamivudine 150 mg/ Zidovudine 300 mg fixed-dose tablets co-packed with Efavirenz 600 mg tablets for the treatment of HIV-1 infection. There is no previous version of this co-packaged product approved by US FDA, the company said.

This is the company's eleventh approval in the ARV (anti-retroviral) segment and the company expects the fresh NDA to help it retain its position as a strong player in the ARV segment. Being a fully integrated player, the company said it is geared up to penetrate into branded generic formulations for various regulated markets.

The company's Lamivudine/ Zidovudine fixed dose combination tablet are a version of Combivir tablets manufactured by GlaxoSmithkline, and the Efavirenz tablets are a version of Sustiva tablets manufactured by Bristol Myers-Squibb, the release said.

More Stories on : Announcements | Pharmaceuticals | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Viceroy Hotels clears equity, warrants issues


Siemens bags orders worth Rs 68 cr
Aurobindo drug gets US FDA nod
Certification for Hikal's drug
Avon allots shares to non-promoters
Jet Airways defers FCCB, GDR issues
Wockhardt gets nod to raise $800 m
Deutsche to invest $75 m in Sical
Fidelity hikes stake in Dr Reddy's
Rajesh Exports buys out OyzterBay chain
Writer Corpn eyeing global acquisition
Lifeline takes over Karur hospital
Coromandel to buy stake in FICOM
Archidply sets up unit in Uttaranchal
Recaero sets up Indian subsidiary in Bangalore
Suzlon Energy to invest $60 m in China
AP Paper Mills strike called off
`Gulf Oil entry into new areas to unlock shareholder value'
Tata Salt's gesture to poor kids
Essar group now into telecom infrastructure
Dunlop to reopen unit at Ambattur on April 10
Chevrolet Aveo range starts at Rs 5.55 lakh
SKF India to roll out new products from Pune unit
Govt questions Cairn's reserve claims
Taurus plans to make India Asia Pacific hub
Pasrija takes over as OIL CMD



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line